| Literature DB >> 17546638 |
Sotirios G Papageorgiou1, Stefanos Lambropoulos, Vassiliki Pappa, Christina Economopoulou, Frinta Kontsioti, Efstathios Papageorgiou, Panagiotis Tsirigotis, John Dervenoulas, Theofanis Economopoulos.
Abstract
The p15 gene is a putative tumor suppressor gene that encodes a member of the cyclin dependent kinase inhibitors. Inactivation of p15 by promoter hypermethylation has been postulated as a possible way by which tumor suppressor genes are inactivated in cancer. In this study, we examined the methylation status of the p15 gene promoter in 34 patients with B-Chronic Lymphocytic Leukemia (B-CLL), by the Methylation-Specific Polymerase Chain Reaction. Selective methylation of the p15 gene promoter was found in 4/34 cases (11.8%). According to Rai staging, the four patients with methylated p15 were staged on diagnosis as: 1 on Stage 0, 1 in Stage I, 1 in Stage III, and 1 in Stage IV. Our results suggest that methylation of the p15 gene promoter can be detected in a small subset of B-CLL patients, at all stages of the disease. 2007 Wiley-Liss, IncEntities:
Mesh:
Substances:
Year: 2007 PMID: 17546638 DOI: 10.1002/ajh.20914
Source DB: PubMed Journal: Am J Hematol ISSN: 0361-8609 Impact factor: 10.047